These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10992004)

  • 61. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and pharmacological characterization of a novel, highly potent, peptidomimetic delta-opioid radioantagonist, [3H]Tyr-Tic-(2S,3R)-beta-MePhe-Phe-OH.
    Birkas E; Kertesz I; Toth G; Bakota L; Gulya K; Szucs M
    Neuropeptides; 2008 Feb; 42(1):57-67. PubMed ID: 18068762
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NK(3) receptor agonism promotes episodic-like memory in mice.
    Zlomuzica A; Dere E; Huston JP; de Souza Silva MA
    Neurobiol Learn Mem; 2008 Sep; 90(2):420-5. PubMed ID: 18556225
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Central injection of senktide, an NK3 receptor agonist, or neuropeptide Y inhibits LH secretion and induces different patterns of Fos expression in the rat hypothalamus.
    Sandoval-Guzmán T; Rance NE
    Brain Res; 2004 Nov; 1026(2):307-12. PubMed ID: 15488494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
    Field MJ; McCleary S; Boden P; Suman-Chauhan N; Hughes J; Singh L
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1226-32. PubMed ID: 9618426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. NK-3 receptors mediate enhancement of substance P release from capsaicin-sensitive spinal cord afferent terminals.
    Schmid G; Carità F; Bonanno G; Raiteri M
    Br J Pharmacol; 1998 Oct; 125(4):621-6. PubMed ID: 9831894
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
    Douglas SA; Behm DJ; Aiyar NV; Naselsky D; Disa J; Brooks DP; Ohlstein EH; Gleason JG; Sarau HM; Foley JJ; Buckley PT; Schmidt DB; Wixted WE; Widdowson K; Riley G; Jin J; Gallagher TF; Schmidt SJ; Ridgers L; Christmann LT; Keenan RM; Knight SD; Dhanak D
    Br J Pharmacol; 2005 Jul; 145(5):620-35. PubMed ID: 15852036
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of a dipeptide chemical library in the development of non-peptide tachykinin NK3 receptor selective antagonists.
    Boden P; Eden JM; Hodgson J; Horwell DC; Hughes J; McKnight AT; Lewthwaite RA; Pritchard MC; Raphy J; Meecham K; Ratcliffe GS; Suman-Chauhan N; Woodruff GN
    J Med Chem; 1996 Apr; 39(8):1664-75. PubMed ID: 8648606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro and in vivo pharmacological characterization of the novel NK₁ receptor selective antagonist Netupitant.
    Rizzi A; Campi B; Camarda V; Molinari S; Cantoreggi S; Regoli D; Pietra C; Calo' G
    Peptides; 2012 Sep; 37(1):86-97. PubMed ID: 22732666
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Signal transduction mechanisms of recombinant bovine neurokinin-2 receptor stably expressed in baby hamster kidney cells.
    Eistetter HR; Mills A; Arkinstall SJ
    J Cell Biochem; 1993 May; 52(1):84-91. PubMed ID: 8391539
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR; Katsuno T; Mantey SA; Pradhan TK; Weber HC; Coy DH; Battey JF; Jensen RT
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1202-11. PubMed ID: 10454496
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Molecular and pharmacological characterization of a functional tachykinin NK3 receptor cloned from the rabbit iris sphincter muscle.
    Medhurst AD; Hirst WD; Jerman JC; Meakin J; Roberts JC; Testa T; Smart D
    Br J Pharmacol; 1999 Oct; 128(3):627-36. PubMed ID: 10516642
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons.
    Myers AC; Goldie RG; Hay DW
    Am J Respir Crit Care Med; 2005 Feb; 171(3):212-6. PubMed ID: 15477495
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.
    Krause JE; Staveteig PT; Mentzer JN; Schmidt SK; Tucker JB; Brodbeck RM; Bu JY; Karpitskiy VV
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):310-5. PubMed ID: 8990205
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist.
    Swaney JS; Chapman C; Correa LD; Stebbins KJ; Broadhead AR; Bain G; Santini AM; Darlington J; King CD; Baccei CS; Lee C; Parr TA; Roppe JR; Seiders TJ; Ziff J; Prasit P; Hutchinson JH; Evans JF; Lorrain DS
    J Pharmacol Exp Ther; 2011 Mar; 336(3):693-700. PubMed ID: 21159750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. AL-8810: a novel prostaglandin F2 alpha analog with selective antagonist effects at the prostaglandin F2 alpha (FP) receptor.
    Griffin BW; Klimko P; Crider JY; Sharif NA
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1278-84. PubMed ID: 10454504
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbil mesencephalic cell cultures.
    Alonso R; Fournier M; Carayon P; Petitpretre G; Le Fur G; Soubrié P
    Eur J Neurosci; 1996 Apr; 8(4):801-8. PubMed ID: 9081631
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Substance P regulates PTH secretion through the neurokinin-1 receptor.
    Galvin RJ; Babbey LE; Hipskind PA; Lamar T; George CA; Baez M; Gitter BD
    Biochem Biophys Res Commun; 2000 Apr; 270(1):230-4. PubMed ID: 10733932
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure.
    Cloutier F; Ongali B; Deschamps K; Brouillette J; Neugebauer W; Couture R
    Br J Pharmacol; 2006 May; 148(1):25-38. PubMed ID: 16491095
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functional characterization of the nonpeptide neurokinin3 (NK3) receptor antagonist, SR142801 on the human NK3 receptor expressed in Chinese hamster ovary cells.
    Oury-Donat F; Carayon P; Thurneyssen O; Pailhon V; Emonds-Alt X; Soubrié P; Le Fur G
    J Pharmacol Exp Ther; 1995 Jul; 274(1):148-54. PubMed ID: 7616392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.